Table 1.
Characteristic | All respondents (N = 169) |
---|---|
Classification, n (%) | |
ILD expert | 69 (40.8) |
Community pulmonologist | 100 (59.2) |
Years practicing pulmonary medicine, n (%) | |
1–5 | 22 (13.0) |
6–10 | 35 (20.7) |
11–20 | 60 (35.5) |
21–30 | 47 (27.8) |
31–40 | 5 (3.0) |
Professional time spent in direct patient care, n (%) | |
21–40% | 3 (1.8) |
41–60% | 14 (8.3) |
61–80% | 36 (21.3) |
81–100% | 116 (68.6) |
Primary practice setting, n (%) | |
Academic | 97 (57.4) |
Private practice | 41 (24.3) |
Community | 30 (17.8) |
Other | 1 (0.6) |
Patients with IPF in the practice, mean (SD), n | 66 (109) |
Patients treated with an approved antifibrotic, mean (SD), % | 55.2 (28.8) |
ILD interstitial lung disease, IPF idiopathic pulmonary fibrosis, SD standard deviation